Artificial ovary
US-2017369851-A1 · Dec 28, 2017 · US
US9976119B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9976119-B2 |
| Application number | US-201615157201-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 17, 2016 |
| Priority date | Jun 1, 2011 |
| Publication date | May 22, 2018 |
| Grant date | May 22, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to compositions and methods for the handling of processed sperm including samples that are freshly collected, those transported as fresh samples, samples that are frozen and thawed, those sorted into one or more subpopulations, and those that are otherwise processed or handled that impose trauma on the cell. Trauma can reduce the motility, fertility, viability and overall integrity of the sperm and reduce the ability to fertilize, produce an embryo and a healthy offspring. The present invention relates to novel compounds that can be added to the sperm cell sample to reduce the traumatic effects of physical stress during mild as well as extensive sperm cell processing, methods of using the compounds in standard sperm processing procedures, the end products made from these methods including sperm and embryos, as well as methods of using those end products in assisted reproductive biology techniques in animals.
Opening claim text (preview).
The invention claimed is: 1. A method of fertilizing one or more eggs, comprising the steps of: providing a sperm cell sample in a media making a sperm cell composition, wherein the media comprises vitamin B12, or a vitamin B12 vitamer, at a concentration of about 0.01 mg/ml to 1 mg/ml and alpha-ketoglutarate; and contacting the one or more eggs with one or more sperm cells from the sperm cell composition. 2. The method of claim 1 , wherein the concentration of the vitamin B12, or the vitamin B12 vitamer, in the media is selected from the group consisting of: 0.01 to 0.25 mg/ml; 0.01 to 0.5 mg/ml; 0.05 to 0.1 mg/ml; 0.05 to 1.0 mg/ml; 0.1 to 0.25 mg/ml; 0.1 to 0.5 mg/ml; 0.1 to 1 mg/ml; 0.15 to 0.45 mg/ml; 0.15 to 0.5 mg/ml; 0.25 to 0.35 mg/ml; 0.25 to 0.5 mg/ml; 0.25 to 1 mg/ml; 0.35 to 0.5 mg/ml; 0.35 to 1 mg/ml; and 0.5 to 1 mg/ml. 3. The method of claim 1 , wherein the concentration of the vitamin B12, or the vitamin B12 vitamer, in the media is selected from the group consisting of: about 0.05 mg/ml; about 0.1 mg/ml; about 0.15 mg/ml; about 0.25 mg/ml; about 0.35 mg/ml; about 0.45 mg/ml; and about 0.5 mg/ml. 4. The method of claim 1 , wherein the concentration of the vitamin B12, or the vitamin B12 vitamer, in the media is about 0.15 mg/ml, about 0.25 mg/ml or about 0.35 mg/ml. 5. The method of claim 1 , wherein the concentration of the vitamin B12, or the vitamin B12 vitamer, in the media is about 0.25 mg/ml. 6. The method of claim 1 , wherein the concentration of the alpha-ketoglutarate in the media is about 0.15 mg/ml to 0.5 mg/ml. 7. The method of claim 1 , wherein the sperm cell sample has been sex-sorted. 8. The method of claim 1 , wherein the sperm cell sample has been processed by ablating unwanted cells. 9. The method of claim 1 , further comprising the step of freezing and thawing the sperm cell sample or the sperm cell composition. 10. The method of claim 1 , wherein the sperm cell sample is derived from a human, bovine, swine, ovine, equine, deer, elk, buffalo, canine, feline, chimpanzee or gorilla, or a whale, dolphin or other marine mammal. 11. A method of fertilizing one or more eggs, comprising the steps of: providing a sex-sorted sperm cell sample, or a sperm cell sample processed by ablating unwanted cells, in a media making a sperm cell composition, wherein the media comprises vitamin B12, or a vitamin B12 vitamer, at a concentration of about 0.01 mg/ml to 1 mg/ml; and contacting the one or more eggs with one or more sperm cells from the sperm cell composition. 12. The method of claim 11 , wherein the concentration of the vitamin B12, or the vitamin B12 vitamer, in the media is about 0.15 mg/ml, about 0.25 mg/ml or about 0.35 mg/ml. 13. The method of claim 11 , wherein the concentration of the vitamin B12, or the vitamin B12 vitamer, in the media is about 0.25 mg/ml. 14. The method of claim 11 , wherein the media further comprises alpha-ketoglutarate. 15. The method of claim 11 , further comprising the step of freezing and thawing the sperm cell sample or the sperm cell composition. 16. The method of claim 11 , wherein the sperm cell sample is derived from a human, bovine, swine, ovine, equine, deer, elk, buffalo, canine, feline, chimpanzee or gorilla, or a whale, dolphin or other marine mammal.
Drugs for genital or sexual disorders (for disorders of sex hormones A61P5/24); Contraceptives · CPC title
the analysis being performed on a sample stream · CPC title
Oocytes, oogonia (fertilised oocytes C12N5/0604) · CPC title
Sperm cells, spermatogonia · CPC title
sorting of gametes, e.g. according to sex or motility · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.